Veronica Crespi

Veronica Crespi

Auto-generated profile, based on publicly available information

Veronica Crespi

INSERM U1248 Pharmacology & Transplantation, Univ. Limoges

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
MLMounia Lakli
Mounia Lakli
JDJulie Dumont
Julie Dumont
VVVirginie Vauthier
Virginie Vauthier
JCJulie Charton
Julie Charton
VCVeronica Crespi
Veronica Crespi
Thomas FalguièresThomas Falguières
Thomas Falguières
ABCB4 is located at the canalicular membrane of hepatocytes and is responsible for the secretion of phosphatidylcholine into bile. Genetic variations of this transporter are correlated with rare cholestatic liver diseases, the most severe being progressive familial intrahepatic cholestasis type 3 (PFIC3). PFIC3 patients most often require liver transplantation. In this context of unmet medical need, we developed a high-content screening approach to identify small molecules able to correct ABCB4 molecular defects. Intracellularly-retained variants of ABCB4 were expressed in cell models and their maturation, cellular localization and function were analyzed after treatment with the molecules identified by high-content screening. In total, six hits were identified by high-content screening. Three of them were able to correct the maturation and canalicular localization of two distinct intracellularly-retained ABCB4 variants; one molecule was able to significantly restore the function of two ABCB4 variants. In addition, in silico molecular docking calculations suggest that the identified hits may interact with wild type ABCB4 residues involved in ATP binding/hydrolysis. Our results pave the way for their optimization in order to provide new drug candidates as potential alternative to liver transplantation for patients with severe forms of ABCB4-related diseases, including PFIC3.

20 April 2023 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
ÁTÁgota Tóth
Ágota Tóth
VCVeronica Crespi
Veronica Crespi
AJAngelika Janaszkiewicz
Angelika Janaszkiewicz
FMFlorent Di Meo
Florent Di Meo
ATP‐binding cassette C‐family drug membrane transporters play an important role in local pharmacokinetics, that is, drug concentration in cellular compartments. From the structural point of view, only the bovine ortholog of the multidrug resistance‐associated protein 1 (bMRP1) has been resolved. We here used μs‐scaled molecular dynamics simulations to investigate the structure and dynamics of the bovine multidrug resistance‐associated protein 1 in pre‐ and post‐hydrolysis functional states. The present work aims to examine the slight but likely relevant structural differences between pre‐ and post‐hydrolysis states of outward‐facing conformations as well as the interactions between the multidrug resistance‐associated protein 1 and the surrounding lipid bilayer. Global conformational dynamics show unfavourable extracellular opening associated with nucleotide‐binding domain dimerization indicating that the post‐hydrolysis state adopts a close‐cleft conformation rather than an outward‐open conformation. Our present simulations also highlight persistent interactions with annular cholesterol molecules and the expected active role of lipid bilayer in the allosteric communication between distant domains of the transporter.

22 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
VCVeronica Crespi
Veronica Crespi
ÁTÁgota Tóth
Ágota Tóth
AJAngelika Janaszkiewicz
Angelika Janaszkiewicz
TFThomas Falguières
Thomas Falguières
FMFlorent Di Meo
Florent Di Meo
ABCB4 is an ATP-binding cassette transporter expressed at the canalicular membrane of hepatocytes and responsible for translocating phosphatidylcholine into bile. Despite the recent cryo-EM structures of ABCB4, knowledge about the molecular mechanism of phosphatidylcholine transport remains fragmented. In this study, we used all-atom molecular dynamics simulations to investigate ABCB4 dynamics during its transport cycle, leveraging both symmetric and asymmetric membrane models. Our results demonstrate that membrane composition influences the local conformational dynamics of ABCB4, revealing distinct lipid-binding patterns across different conformers, particularly for cholesterol. We explored the two potential mechanisms for phosphatidylcholine translocation: the canonical ATP-driven alternating access model and the “credit-card swipe” model. Critical residues were identified for phosphatidylcholine binding and transport pathway modulation, supporting the canonical mechanism while also indicating a possible additional pathway. The conformer-specific roles of kinking in transmembrane helices (TMH4 and TMH10) were highlighted as key events in substrate translocation. Overall, ABCB4 may utilize a cooperative transport mechanism, integrating elements of both models to facilitate efficient phosphatidylcholine motion across the membrane. This study provides new insights into the relationship between membrane environment and ABCB4 function, contributing to our understanding of its role in bile physiology and susceptibility to genetic and xenobiotic influences.

9 April 2026
Verified
Thesis
Closed access
VCVeronica Crespi
Veronica Crespi
ABCB4 est un transporteur de la famille des protéines ABC (ATP-binding cassette), exprimé dans la membrane canaliculaire de l'hépatocyte. Son rôle principal est de transloquer la phosphatidylcholine (PC) à travers la membrane, un des composants majeurs des micelles mixtes de la bile, avec les sels biliaires et le cholestérol. La sécrétion biliaire constitue une fonction hépatique essentielle, indispensable à la digestion des lipides et à l’élimination des xénobiotiques. Le dysfonctionnement de ce transporteur est étroitement lié à des maladies hépatiques ; des variations génétiques faux-sens du gène ABCB4 peuvent provoquer une cholestase hépatique intra-hépatique progressive de type 3 (PFIC3). Par exemple, les mutations I490T, I551F et L556R ont été identifiées chez des patients atteints de PFIC3 et ont été associées à des défauts de trafic protéique dus à une rétention dans le réticulum endoplasmique (RE). Dans ce travail, nous avons étudié cinq états clés du cycle de transport d’ABCB4: apo IFhABCB4 (PDB : 7niu), IFhABCB4-(ATP)2, IFhABCB4-PC (PDB : 7niv), IFhABCB4-PC-(ATP)2, et CChABCB4-(ATP)2 (PDB : 6s7p). Des simulations de dynamique moléculaire (MD) à l’échelle de la microseconde, avec une résolution atomique complète, ont été réalisées pour chaque conformation, insérée dans des bicouches lipidiques présentant deux compositions différentes (symétrique et asymétrique), afin d’étudier l’impact de la composition lipidique sur la dynamique structurale d’ABCB4.Grâce à des calculs alchimiques, nous avons examiné l’impact des mutations I490T, I551F et L556R sur la structure locale de la protéine. Notre objectif était de fournir des informations précieuses sur les altérations fonctionnelles. Les calculs d’énergie libre ont indiqué une modulation limitée de l’arrangement local des résidus voisins autour des mutations. Ainsi, des simulations MD à l’échelle de la microseconde ont également été réalisées dans deux membranes mimant celles du RE, afin d’explorer la dynamique de la protéine et de mieux comprendre l’impact des mutations. Enfin, des composés ayant montré expérimentalement une capacité à restaurer partiellement la fonction du transporteur ont été dockés sur la protéine sauvage ainsi que sur les mutants.